HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 1 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,690,000 | -53.6% | 5,113,958 | +1.1% | 0.05% | -52.7% |
| Q2 2020 | $3,643,000 | +121.5% | 5,060,160 | 0.0% | 0.11% | +77.4% |
| Q1 2020 | $1,645,000 | -53.1% | 5,060,160 | +1.2% | 0.06% | -42.6% |
| Q4 2019 | $3,510,000 | +5.6% | 5,000,000 | 0.0% | 0.11% | -12.2% |
| Q3 2019 | $3,323,000 | – | 5,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 466 | $2,000 | 0.00% |